Trusted by over 100K subscribers

100% online process

No memberships requirements

FDA-Regulated Pharmacies

Transparent pricing, no hidden fees

Board certified physicians

US sourced ingredients

Important Safety Information for 

Zepbound® KwikPen®

Warning: Risk of Thyroid C-Cell Tumors

In rats, Zepbound® caused thyroid tumors, including thyroid cancer. It is not known whether Zepbound® causes thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in humans.

Tell your healthcare provider right away if you develop:

  • A lump or swelling in your neck
  • Hoarseness
  • Trouble swallowing
  • Shortness of breath

These may be symptoms of thyroid cancer.

Do not use Zepbound® if:

  • You or anyone in your family has ever had medullary thyroid carcinoma (MTC)
  • You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

What Is Zepbound® Used For?

Zepbound® is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with:

  • A BMI of 30 kg/m² or greater (obesity), or
  • A BMI of 27 kg/m² or greater (overweight) and at least one weight-related condition such as:
    • High blood pressure
    • High cholesterol
    • Type 2 diabetes
    • Obstructive sleep apnea
    • Cardiovascular disease

Limitations of Use

  • Zepbound® should not be used with other tirzepatide-containing products or other GLP-1 receptor agonists.
  • The safety and effectiveness of using Zepbound® with other weight-loss products have not been established.
  • Zepbound® has not been studied in patients with a history of pancreatitis.

Who Should Not Use Zepbound®?

Do not use Zepbound® if:

  • You or anyone in your family has had medullary thyroid carcinoma (MTC).
  • You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • You have had an allergic reaction to Zepbound®.

How Should I Take Zepbound®?

  • Zepbound® may be taken with or without food.
  • It is injected under the skin once weekly on the same day each week.
  • Injection sites include:
    • Stomach
    • Thigh
    • Upper arm
  • Your Good Life-affiliated provider may increase your dose every four weeks.

Do not change your dose or stop taking Zepbound® without speaking with your provider.

Before Taking Zepbound®

Tell your provider about all medications you take, including prescription drugs, over-the-counter medications, vitamins, herbal products, and supplements.

Important Medication Interactions

Diabetes Medications

Including insulin and sulfonylureas such as:

  • Amaryl®
  • Glucotrol XL®

Other Oral Medications

Zepbound® delays stomach emptying and may affect how oral medications are absorbed.

Hormonal Birth Control

Zepbound® may reduce the effectiveness of oral contraceptives.

Use a non-oral contraceptive or add a barrier method:

  • For 4 weeks after starting treatment
  • For 4 weeks after each dose increase

Other GLP-1 Medications

Do not take Zepbound® with:

  • Mounjaro®
  • Wegovy®
  • Ozempic®
  • Saxenda®
  • Victoza®
  • Byetta®
  • Bydureon®

Other Weight-Loss Products

Including dietary supplements.

Tell Your Provider If You Have Ever Had:

  • Type 1 or Type 2 diabetes
  • Thyroid cancer
  • Gastrointestinal disease
  • Pancreatitis
  • Kidney disease
  • Diabetic retinopathy
  • Depression
  • Suicidal thoughts or behavior

Pregnancy and Breastfeeding

Tell your provider if you are:

  • Pregnant
  • Planning to become pregnant
  • Breastfeeding

Pregnancy

Zepbound® should not be used during pregnancy. Weight loss during pregnancy may harm an unborn baby.

Birth Control

If you are of reproductive potential, use a non-oral contraceptive or barrier method for:

  • Four weeks after starting treatment
  • Four weeks after each dose increase until maintenance dosing

Breastfeeding

It is unknown whether Zepbound® passes into breast milk. Discuss the risks and benefits with your provider.

Pregnancy Registry

Pregnant patients exposed to Zepbound® and healthcare providers are encouraged to contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979).

Serious Side Effects

Seek emergency medical attention or call 911 if needed.

Serious side effects may include:

Thyroid C-Cell Tumors

Watch for:

  • Lump or swelling in the neck
  • Hoarseness
  • Trouble swallowing
  • Shortness of breath

Severe Gastrointestinal Disease

Symptoms may include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Stomach pain

Acute Kidney Injury

Severe vomiting or diarrhea may cause dehydration and kidney problems.

Acute Gallbladder Disease

Tell your provider immediately if you experience:

  • Upper abdominal pain
  • Yellowing of the skin or eyes
  • Fever
  • Clay-colored stools

Acute Pancreatitis

Symptoms include:

  • Severe abdominal pain that does not go away
  • Pain radiating to the back
  • Vomiting

Serious Allergic Reactions

Stop taking Zepbound® and seek immediate care if you develop:

  • Swelling of the face, lips, tongue, or throat
  • Severe rash or itching
  • Difficulty breathing or swallowing
  • Rapid heartbeat
  • Fainting or dizziness

Low Blood Sugar (Hypoglycemia)

Symptoms include:

  • Dizziness
  • Blurred vision
  • Mood changes
  • Sweating
  • Fast heartbeat

Diabetic Retinopathy Complications

Tell your provider if you experience changes in vision.

Suicidal Thoughts or Behavior

Contact your healthcare provider immediately if you notice new or worsening:

  • Mood changes
  • Behaviors
  • Thoughts
  • Feelings

Never Share a Pen

Sharing injection pens can transmit infections.

Common Side Effects

The most common side effects of Zepbound® include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Stomach pain
  • Indigestion
  • Injection site reactions
  • Fatigue
  • Allergic reactions
  • Belching
  • Hair loss
  • Gastroesophageal reflux disease (heartburn)

Reporting Side Effects

You are encouraged to report negative side effects of prescription products to the FDA.

Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

This information is not comprehensive. Please see the full Prescribing Information for complete safety information.

‍